|
1
|
Wang X: Investigational anti-inflammatory
agents for the treatment of ischaemic brain injury. Expert Opin
Investig Drugs. 14:393–409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Durukan A and Tatlisumak T: Acute ischemic
stroke: Overview of major experimental rodent models,
pathophysiology, and therapy of focal cerebral ischemia. Pharmacol
Biochem Behav. 87:179–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arenillas JF, Sobrino T, Castillo J and
Dávalos A: The role of angiogenesis in damage and recovery from
ischemic stroke. Curr Treat Options Cardiovasc Med. 9:205–212.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Navarro-Sobrino M, Rosell A,
Hernández-Guillamon M, Penalba A, Boada C, Domingues-Montanari S,
Ribó M, Alvarez-Sabín J and Montaner J: A large screening of
angiogenesis biomarkers and their association with neurological
outcome after ischemic stroke. Atherosclerosis. 216:205–211. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koutsis G, Siasos G and Spengos K: The
emerging role of microRNA in stroke. Curr Top Med Chem.
13:1573–1588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng T, Jia YJ, Wen QQ, Guan WJ, Zhao EY
and Zhang BA: Expression of microRNA in neonatal rats with
hypoxic-ischemic brain damage. Chin J Contemp Pediatr. 12:373–376.
2012.In Chinese.
|
|
7
|
Hatse S, Brouwers B, Dalmasso B, Laenen A,
Kenis C, Schöffski P and Wildiers H: Circulating MicroRNAs as
easy-to-measure aging biomarkers in older breast cancer patients:
Correlation with chronological age but not with fitness/frailty
status. PLoS One. 9:e1106442014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mosakhani N, Lahti L, Borze I,
Karjalainen-Lindsberg ML, Sundström J, Ristamäki R, Osterlund P,
Knuutila S and Sarhadi VK: MicroRNA profiling predicts survival in
anti-EGFR treated chemorefractory metastatic colorectal cancer
patients with wild-type KRAS and BRAF. Cancer Genet. 205:545–551.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W and He F: Monocyte to macrophage
differentiation-associated (MMD) targeted by miR-140-5p regulates
tumor growth in non-small cell lung cancer. Biochem Biophys Res
Commun. 450:844–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kai Y, Peng W, Ling W, Jiebing h and Zhuan
B: Reciprocal effects between microRNA-140-5p and ADAM10 suppress
migration and invasion of human tongue cancer cells. Biochem
Biophys Res Commun. 448:308–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
National Research Council: Guide for the
Care and Use of Laboratory Animals. 8th edition. National Academies
Press; 2011
|
|
13
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen KC, Sung PL, Yen MS, Chuang CM, Liou
WS and Wang PH: MicroRNAs regulate several functions of normal
tissues and malignancies. Taiwan J Obstet Gynecol. 52:465–469.
2013. View Article : Google Scholar
|
|
17
|
Chan SH and Wang LH: Regulation of cancer
metastasis by microRNAs. J Biomed Sci. 22:92015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen J, Yang X, Xie B, Chen Y, Swaim M,
Hackett SF and Campochiaro PA: MicroRNAs regulate ocular
neovascularization. Mol Ther. 16:1208–1216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dharap A, Bowen K, Place R, Li LC and
Vemuganti R: Transient focal ischemia induces extensive temporal
changes in rat cerebral microRNAome. J Cereb Blood Flow Metab.
29:675–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu CF, Yu CH and Li YM: Regulation of
hepatic microRNA expression in response to ischemic preconditioning
following ischemia/reperfusion injury in mice. OMICS. 13:513–520.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park CS and Tang SJ: Regulation of
microRNA expression by induction of bidirectional synaptic
plasticity. J Mol Neurosci. 38:50–56. 2009. View Article : Google Scholar
|
|
23
|
Viader A, Chang LW, Fahrner T, Nagarajan R
and Milbrandt J: MicroRNAs modulate Schwann cell response to nerve
injury by reinforcing transcriptional silencing of
dedifferentiation-related genes. J Neurosci. 31:17358–17369. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miteff F, Levi CR, Bateman GA, Spratt N,
McElduff P and Parsons MW: The independent predictive utility of
computed tomography angiographic collateral status in acute
ischaemic stroke. Brain. 132:2231–2238. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liebeskind DS, Cotsonis GA, Saver JL, Lynn
MJ, Turan TN, Cloft HJ and Chimowitz MI; Warfarin-Aspirin
Symptomatic Intracranial Disease (WASID) Investigators: Collaterals
dramatically alter stroke risk in intracranial atherosclerosis. Ann
Neurol. 69:963–974. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rusanen H, Saarinen JT and Sillanpää N:
Collateral Circulation Predicts the Size of the Infarct Core and
the Proportion of Salvageable Penumbra in Hyperacute Ischemic
Stroke Patients Treated with Intravenous Thrombolysis. Cerebrovasc
Dis. 40:182–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ernst M, Forkert ND, Brehmer L, Thomalla
G, Siemonsen S, Fiehler J and Kemmling A: Prediction of infarction
and reperfusion in stroke by flow- and volume-weighted collateral
signal in MR angiography. AJNR Am J Neuroradiol. 36:275–282. 2015.
View Article : Google Scholar
|
|
28
|
Folkman J and Shing Y: Angiogenesis. J
Biol Chem. 267:10931–10934. 1992.PubMed/NCBI
|
|
29
|
Henry TD: Therapeutic angiogenesis. BMJ.
318:1536–1539. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beck H and Plate KH: Angiogenesis after
cerebral ischemia. Acta Neuropathol. 117:481–496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsui M and Tabata Y: Enhanced
angiogenesis by multiple release of platelet-rich plasma contents
and basic fibroblast growth factor from gelatin hydrogels. Acta
Biomater. 8:1792–1801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Spyridopoulos I, Luedemann C, Chen D,
Kearney M, Chen D, Murohara T, Principe N, Isner JM and Losordo DW:
Divergence of angiogenic and vascular permeability signaling by
VEGF: Inhibition of protein kinase C suppresses VEGF-induced
angiogenesis, but promotes VEGF-induced, NO-dependent vascular
permeability. Arterioscler Thromb Vasc Biol. 22:901–906. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Plate KH, Beck H, Danner S, Allegrini PR
and Wiessner C: Cell type specific upregulation of vascular
endothelial growth factor in an MCA-occlusion model of cerebral
infarct. J Neuropathol Exp Neurol. 58:654–666. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Banai S, Jaklitsch MT, Shou M, Lazarous
DF, Scheinowitz M, Biro S, Epstein SE and Unger EF:
Angiogenic-induced enhancement of collateral blood flow to ischemic
myocardium by vascular endothelial growth factor in dogs.
Circulation. 89:2183–2189. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lennmyr F, Ata KA, Funa K, Olsson Y and
Terént A: Expression of vascular endothelial growth factor (VEGF)
and its receptors (Flt-1 and Flk-1) following permanent and
transient occlusion of the middle cerebral artery in the rat. J
Neuropathol Exp Neurol. 57:874–882. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Marti HJ, Bernaudin M, Bellail A, Schoch
H, Euler M, Petit E and Risau W: Hypoxia-induced vascular
endothelial growth factor expression precedes neovascularization
after cerebral ischemia. Am J Pathol. 156:965–976. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hayashi T, Abe K, Suzuki H and Itoyama Y:
Rapid induction of vascular endothelial growth factor gene
expression after transient middle cerebral artery occlusion in
rats. Stroke. 28:2039–2044. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang ZG, Zhang L, Jiang Q, Zhang R,
Davies K, Powers C, Bruggen N and Chopp M: VEGF enhances
angiogenesis and promotes blood-brain barrier leakage in the
ischemic brain. J Clin Invest. 106:829–838. 2000. View Article : Google Scholar : PubMed/NCBI
|
